Rhenman & Partners Asset Management AB - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$420,000
-18.1%
30,0990.0%0.06%
-25.9%
Q1 2017$513,000
+65.5%
30,0990.0%0.08%
+37.3%
Q4 2016$310,000
-99.9%
30,0990.0%0.06%
+22.9%
Q3 2016$304,301,000
+89929.9%
30,0990.0%0.05%
-20.0%
Q2 2016$338,00030,0990.06%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
BVF INC/IL 1,817,138$30,582,0002.98%
SENZAR ASSET MANAGEMENT, LLC 29,821$502,0001.45%
INGALLS & SNYDER LLC 1,337,862$22,516,0001.04%
Matarin Capital Management, LLC 316,858$5,332,720,0000.39%
KNOTT DAVID M 51,557$868,0000.32%
PRINCETON CAPITAL MANAGEMENT LLC 16,582$279,0000.12%
GSA CAPITAL PARTNERS LLP 123,700$2,082,0000.10%
Spark Investment Management LLC 97,200$1,635,0000.10%
ACADIAN ASSET MANAGEMENT LLC 941,282$15,841,0000.07%
Municipal Employees' Retirement System of Michigan 67,220$1,131,0000.06%
View complete list of CONCERT PHARMACEUTICALS INC shareholders